3 | SEC Filings Hub

Filing metadata

Accession number: 0001213900-24-076596
Form type: Form 3
Filer: Oruka Therapeutics, Inc.
CIK: CIK 907654
Filed: Sep 06, 2024
Reporting period: Aug 29, 2024
Description: Initial ownership

Documents

0001213900-24-076596-index.htm

Complete submission

0001213900-24-076596.txt

directory listing

Filed by

Oruka Therapeutics, Inc.